Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | fructose-16-bisphosphatase-related | 0.0325 | 0.3229 | 0.3129 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.061 | 1 | 1 |
Loa Loa (eye worm) | fructose-1,6-bisphosphatase | 0.0325 | 0.3229 | 0.3129 |
Schistosoma mansoni | tyrosine kinase | 0.0328 | 0.3299 | 0.32 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.061 | 1 | 1 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0195 | 0.0145 | 0.0145 |
Schistosoma mansoni | tyrosine kinase | 0.0328 | 0.3299 | 0.32 |
Brugia malayi | fructose-1,6-bisphosphatase | 0.0325 | 0.3229 | 0.3129 |
Echinococcus multilocularis | fructose 1,6 bisphosphatase 1 | 0.0325 | 0.3229 | 0.3229 |
Echinococcus multilocularis | insulin receptor | 0.0195 | 0.0145 | 0.0145 |
Echinococcus granulosus | fructose 16 bisphosphatase 1 | 0.0325 | 0.3229 | 0.3129 |
Schistosoma mansoni | tyrosine kinase | 0.0324 | 0.3217 | 0.3117 |
Schistosoma mansoni | tyrosine kinase | 0.0324 | 0.3217 | 0.3117 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0328 | 0.3299 | 0.32 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.0325 | 0.3229 | 0.5 |
Echinococcus granulosus | epidermal growth factor receptor | 0.061 | 1 | 1 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0328 | 0.3299 | 0.3299 |
Schistosoma mansoni | tyrosine kinase | 0.061 | 1 | 1 |
Toxoplasma gondii | fructose-bisphospatase II | 0.0325 | 0.3229 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0324 | 0.3217 | 0.3117 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0328 | 0.3299 | 0.32 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.0325 | 0.3229 | 0.5 |
Trypanosoma brucei | fructose-1,6-bisphosphatase | 0.0325 | 0.3229 | 0.5 |
Leishmania major | 0.0325 | 0.3229 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | 0 nM | inhibitory concentration required to inhibit Ab1 tyrosine kinase was not determined | ChEMBL. | 15501042 |
IC50 (binding) | 0 nM | Inhibitory concentration required to inhibit Bcr-Abl tyrosine kinase | ChEMBL. | 15501042 |
IC50 (binding) | = 414 nM | Inhibitory concentration required to inhibit PDGFR kinase was determined | ChEMBL. | 15501042 |
Inhibition (binding) | = 49 % | Percent inhibition of Abl tyrosine kinase | ChEMBL. | 15501042 |
Inhibition (binding) | = 49 % | Percent inhibition of Abl tyrosine kinase | ChEMBL. | 15501042 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.